- Home
- LYT vs PTIX Comparison
LYT vs PTIX Comparison
Compare LYT & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYT
- PTIX
- Stock Information
- Founded
- LYT 2020
- PTIX 1994
- Country
- LYT India
- PTIX United States
- Employees
- LYT N/A
- PTIX N/A
- Industry
- LYT EDP Services
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- LYT Technology
- PTIX Health Care
- Exchange
- LYT Nasdaq
- PTIX Nasdaq
- Market Cap
- LYT 3.8M
- PTIX 3.9M
- IPO Year
- LYT 2022
- PTIX 2016
- Fundamental
- Price
- LYT $1.69
- PTIX $0.64
- Analyst Decision
- LYT
- PTIX
- Analyst Count
- LYT 0
- PTIX 0
- Target Price
- LYT N/A
- PTIX N/A
- AVG Volume (30 Days)
- LYT 70.3K
- PTIX 247.6K
- Earning Date
- LYT 08-15-2024
- PTIX 11-29-2024
- Dividend Yield
- LYT N/A
- PTIX N/A
- EPS Growth
- LYT N/A
- PTIX N/A
- EPS
- LYT 0.30
- PTIX N/A
- Revenue
- LYT $21,363,775.00
- PTIX N/A
- Revenue This Year
- LYT N/A
- PTIX N/A
- Revenue Next Year
- LYT N/A
- PTIX N/A
- P/E Ratio
- LYT $5.68
- PTIX N/A
- Revenue Growth
- LYT 12.39
- PTIX N/A
- 52 Week Low
- LYT $1.40
- PTIX $0.49
- 52 Week High
- LYT $18.62
- PTIX $1.87
- Technical
- Relative Strength Index (RSI)
- LYT 44.25
- PTIX 49.61
- Support Level
- LYT $1.67
- PTIX $0.52
- Resistance Level
- LYT $2.04
- PTIX $1.09
- Average True Range (ATR)
- LYT 0.13
- PTIX 0.15
- MACD
- LYT -0.00
- PTIX 0.01
- Stochastic Oscillator
- LYT 16.67
- PTIX 20.91
About LYT Lytus Technologies Holdings PTV. Ltd.
Lytus Technologies Holdings Pvt Ltd is a platform services company providing content streaming/telecasting services to users located all across India. Its scope of business also covers telemedicine services with local assistance through local Health Centers. Through its platform, the customers are well connected via customer premises equipment (CPE) devices/set-top boxes (STBs) and have access to multi-dimensional services including telemedicine service.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.